Navigation Links
LB Broth with 7.5% Glycerol

ProductsLB Broth with 7.5% Glycerol
Company Teknova, Inc.
Item LB Broth with 7.5% Glycerol
Features 
Description 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride, 7.5% Glycerol.
Info Teknova, Inc.
Customer Service: (831) 637-1100
Web site: http://www.teknova.com/

Related medicine products :

1. Super Broth
2. NZ Broth
3. NZY Broth
4. 10X NZY Broth
5. 5X NZY Broth
6. Terrific Broth
7. Terrific Broth with Glycerol
8. Terrific Broth 10X Concentrate
9. AccuGENE Super Broth (Terrific Broth)
10. Terrific Broth, Ready-Made Powder
11. Inoculum Broth with CaCl 2 and Phytone
Other Medicine News:Health News:New upper limit defined for normal ALT in adolescent males 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 2Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2008 Out-of-Pocket Drug Costs 3Health News:Former Texas Assistant Attorney General Pat O'Connell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice 2Health News:American Imaging Management Enters into Agreement with Scott & White Health Plan 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 2Health News:Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need 3Health News:UCSF Medical Center using newest high-tech tool for brain disorders 2
Breaking Medicine Technology:Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 1Imagenetix Inc to Present at the 2009 RedChip New York Equities Conference 14251 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 1Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 2Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 3Oncolytics Biotech 28R 29 Inc Announces Start of Enrolment in U S Phase 2 Melanoma Cancer Clinical Trial 5057 4Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 1Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 2Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 3Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associ 5055 4